- Home
- SPH vs PHVS Comparison
SPH vs PHVS Comparison
Compare SPH & PHVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPH
- PHVS
- Stock Information
- Founded
- SPH 1945
- PHVS 2015
- Country
- SPH United States
- PHVS Netherlands
- Employees
- SPH N/A
- PHVS N/A
- Industry
- SPH Other Specialty Stores
- PHVS Biotechnology: Pharmaceutical Preparations
- Sector
- SPH Consumer Discretionary
- PHVS Health Care
- Exchange
- SPH Nasdaq
- PHVS Nasdaq
- Market Cap
- SPH 1.1B
- PHVS 1.0B
- IPO Year
- SPH 1996
- PHVS 2021
- Fundamental
- Price
- SPH $18.08
- PHVS $18.61
- Analyst Decision
- SPH Hold
- PHVS Strong Buy
- Analyst Count
- SPH 3
- PHVS 5
- Target Price
- SPH $19.67
- PHVS $40.60
- AVG Volume (30 Days)
- SPH 192.2K
- PHVS 106.8K
- Earning Date
- SPH 02-06-2025
- PHVS 11-13-2024
- Dividend Yield
- SPH 7.23%
- PHVS N/A
- EPS Growth
- SPH N/A
- PHVS N/A
- EPS
- SPH 1.14
- PHVS N/A
- Revenue
- SPH $1,327,172,000.00
- PHVS N/A
- Revenue This Year
- SPH N/A
- PHVS N/A
- Revenue Next Year
- SPH $1.22
- PHVS N/A
- P/E Ratio
- SPH $15.77
- PHVS N/A
- Revenue Growth
- SPH N/A
- PHVS N/A
- 52 Week Low
- SPH $15.20
- PHVS $15.37
- 52 Week High
- SPH $22.33
- PHVS $33.00
- Technical
- Relative Strength Index (RSI)
- SPH 39.61
- PHVS 40.29
- Support Level
- SPH $18.80
- PHVS $17.93
- Resistance Level
- SPH $19.41
- PHVS $20.17
- Average True Range (ATR)
- SPH 0.53
- PHVS 1.53
- MACD
- SPH -0.17
- PHVS -0.15
- Stochastic Oscillator
- SPH 13.46
- PHVS 14.38
About SPH Suburban Propane Partners L.P.
Suburban Propane Partners LP distributes propane, fuel oil, and other refined fuels to customers in the East Coast and West Coast regions of the United States. Other operations include natural gas and electricity marketing in the deregulated New York and Pennsylvania markets. The company operates in three segments: Propane; Fuel Oil and Refined Fuels; and Natural Gas and Electricity. It generates maximum revenue from Propane segment.
About PHVS Pharvaris N.V.
Pharvaris NV is a clinical-stage company. It is focused on the discovery and development and commercialization of therapies for rare diseases with significant unmet need, initially focused on angioedema and other bradykinin-mediated diseases. The company's activities are considered to be one segment which comprises the discovery, development and commercialization of oral bradykinin-B2-receptor antagonists .